{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:21:36Z","timestamp":1787656896637,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,30]]},"DOI":"10.7759\/cureus.29776","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T11:58:22Z","timestamp":1664539102000},"source":"Crossref","is-referenced-by-count":2,"title":["Polycystic Ovarian Syndrome in Aging Women: An Observational Study"],"prefix":"10.7759","author":[{"given":"Mukta","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudwita","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Lohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Dureja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/13697130801972304","article-title":"Management of polycystic ovary syndrome in postmenopausal women: a medical black hole","volume":"11","author":"Fenton A","year":"2008","unstructured":"Fenton A, Panay N. Management of polycystic ovary syndrome in postmenopausal women: a medical black hole. Climacteric. 2008, 11:89-90. 10.1080\/13697130801972304","journal-title":"Climacteric"},{"key":"ref2","unstructured":"PCOS effects in ageing women. (2016). Accessed. September 7, 2022: https:\/\/smvayurveda.in\/pcos-effects-ageing\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2020.02.010","article-title":"Aging women with polycystic ovary syndrome: menstrual cycles, metabolic health, and health-related quality of life","volume":"12","author":"Ollila MM","year":"2020","unstructured":"Ollila MM, Piltonen TT, Tapanainen JS, Morin-Papunen L. Aging women with polycystic ovary syndrome: menstrual cycles, metabolic health, and health-related quality of life. Curr Opin Endocr Metab Res. 2020, 12:14-9. 10.1016\/j.coemr.2020.02.010","journal-title":"Curr Opin Endocr Metab Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14382","article-title":"Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: a population-based cohort study","volume":"101","author":"Kujanp\u00e4\u00e4 L","year":"2022","unstructured":"Kujanp\u00e4\u00e4 L, Arffman RK, Pesonen P, et al.. Women with polycystic ovary syndrome are burdened with multimorbidity and medication use independent of body mass index at late fertile age: a population-based cohort study. Acta Obstet Gynecol Scand. 2022, 101:728-36. 10.1111\/aogs.14382","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2020.05.013","article-title":"Polycystic ovary syndrome and aging: health implications after menopause","volume":"139","author":"Helvaci N","year":"2020","unstructured":"Helvaci N, Yildiz BO. Polycystic ovary syndrome and aging: health implications after menopause. Maturitas. 2020, 139:12-9. 10.1016\/j.maturitas.2020.05.013","journal-title":"Maturitas"},{"key":"ref6","unstructured":"Polycystic ovary syndrome (PCOS). (2017). Accessed. September 7, 2022: https:\/\/www.nichd.nih.gov\/health\/topics\/pcos."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19:41-7. 10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.galenos.2021.2021.0077","article-title":"An overview of polycystic ovary syndrome in aging women","volume":"6","author":"\u00c7elik \u00d6","year":"2021","unstructured":"\u00c7elik \u00d6, K\u00f6se MF. An overview of polycystic ovary syndrome in aging women. J Turk Ger Gynecol Assoc. 2021, 6:326-33. 10.4274\/jtgga.galenos.2021.2021.0077","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14117","article-title":"The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome","volume":"92","author":"Meun C","year":"2020","unstructured":"Meun C, Gunning MN, Louwers YV, et al.. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2020, 92:150-8. 10.1111\/cen.14117","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der302","article-title":"Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40","volume":"26","author":"Liang SJ","year":"2011","unstructured":"Liang SJ, Hsu CS, Tzeng CR, Chen CH, Hsu MI. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Hum Reprod. 2011, 26:3443-9. 10.1093\/humrep\/der302","journal-title":"Hum Reprod"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31820209bb","article-title":"Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia","volume":"117","author":"Wang ET","year":"2011","unstructured":"Wang ET, Calderon-Margalit R, Cedars MI, et al.. Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Obstet Gynecol. 2011, 117:6-13. 10.1097\/AOG.0b013e31820209bb","journal-title":"Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.12.017","article-title":"Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life","volume":"107","author":"Pinola P","year":"2017","unstructured":"Pinola P, Puukka K, Piltonen TT, et al.. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life. Fertil Steril. 2017, 107:788-95. 10.1016\/j.fertnstert.2016.12.017","journal-title":"Fertil Steril"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2010.03907.x","article-title":"Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study","volume":"74","author":"Chang AY","year":"2011","unstructured":"Chang AY, Ayers C, Minhajuddin A, et al.. Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. Clin Endocrinol (Oxf). 2011, 74:89-96. 10.1111\/j.1365-2265.2010.03907.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(99)00641-x","article-title":"Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome","volume":"73","author":"Winters SJ","year":"2000","unstructured":"Winters SJ, Talbott E, Guzick DS, Zborowski J, McHugh KP. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril. 2000, 73:724-9. 10.1016\/s0015-0282(99)00641-x","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A 20-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina E","year":"2012","unstructured":"Carmina E, Campagna AM, Lobo RA. A 20-year follow-up of young women with polycystic ovary syndrome. Obstet Gynecol. 2012, 119:263-9. 10.1097\/AOG.0b013e31823f7135","journal-title":"Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry JA","year":"2014","unstructured":"Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014, 20:748-58. 10.1093\/humupd\/dmu012","journal-title":"Hum Reprod Update"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115482-polycystic-ovarian-syndrome-in-aging-women-an-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:24Z","timestamp":1707507624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115482-polycystic-ovarian-syndrome-in-aging-women-an-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.29776","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,30]]}}}